Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-25-035580
Filing Date
2025-07-22
Accepted
2025-07-22 17:06:59
Documents
1
Period of Report
2025-07-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1753218411.html 4  
1 FORM 4 wk-form4_1753218411.xml 4 8422
  Complete submission text file 0001628280-25-035580.txt   9997
Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Issuer) CIK: 0001157601 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O INCYTE CORPORATION 1801 AUGUSTINE CUT-OFF WILMINGTON DE 19803
Business Address
FRIEDMAN PAUL A (Reporting) CIK: 0001236927 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33277 | Film No.: 251140928